Regulations.gov document
02- Reference 01- Draft guidance for industry, “Updating ANDA Labeling After the Marketing…
Supporting & Related Material · FDA-2013-N-0500 · posted Dec 14, 2018
Key facts
| Document ID | FDA-2013-N-0500-0142 |
|---|---|
| Title | 02- Reference 01- Draft guidance for industry, “Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn,” |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2013-N-0500 |
| Posted | Dec 14, 2018 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: